VolitionRx (NYSE:VNRX) Earns “Buy” Rating from D. Boral Capital
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a $5.00 price target on the stock. Other analysts have also recently issued reports about the company. StockNews.com initiated coverage on shares of VolitionRx in […]
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a $5.00 price target on the stock. Other analysts have also recently issued reports about the company. StockNews.com initiated coverage on shares of VolitionRx in […]
